{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:41Z","timestamp":1786119641536,"version":"build-2736575974"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/yco.0b013e3283413451","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T03:15:19Z","timestamp":1289963719000},"page":"34-40","source":"Crossref","is-referenced-by-count":52,"title":["Drug treatment for mood disorders in pregnancy"],"prefix":"10.1097","volume":"24","author":[{"given":"Salvatore","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/GRF.0b013e3181b52930","article-title":"Impact of antenatal and postpartum maternal mental illness: how are the children?","volume":"52","author":"Brand","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"R2-7-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1467-8624.2009.01386.x","article-title":"Mothers' antenatal depression and their children's antisocial outcomes","volume":"81","author":"Hay","year":"2010","journal-title":"Child Dev"},{"key":"R3-7-20210206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2008.06.002","article-title":"Depression and anxiety through pregnancy and the early postpartum: an examination of prospective relationships","volume":"113","author":"Skouteris","year":"2009","journal-title":"J Affect Disord"},{"key":"R4-7-20210206","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R5-7-20210206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2009.05.019","article-title":"Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study","volume":"121","author":"Lee","year":"2010","journal-title":"J Affect Disord"},{"key":"R6-7-20210206","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1523-536X.2008.00296.x","article-title":"Women's attitude, preferences, and perceived barriers to treatment for perinatal depression","volume":"36","author":"Goodman","year":"2009","journal-title":"Birth"},{"key":"R7-7-20210206","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/ps.2010.61.4.386","article-title":"Pregnancy-related discontinuation of antidepressants and depression care visits among Medicaid recipients","volume":"61","author":"Bennett","year":"2010","journal-title":"Psychiatr Serv"},{"key":"R8-7-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00002018-200528020-00005","article-title":"The safety of newer antidepressants in pregnancy and breastfeeding","volume":"28","author":"Gentile","year":"2005","journal-title":"Drug Saf"},{"key":"R10-7-20210206","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R12-7-20210206","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry"},{"key":"R13-7-20210206","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":"Paroxetine and fluoxetine in pregnancy: a multicenter, prospective, controlled study","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R15-7-20210206","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"New Engl J Med"},{"key":"R16-7-20210206","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2165\/00044011-200828110-00006","article-title":"Escitalopram use during pregnancy. Navigating toward international guidelines and the real world","volume":"28","author":"Gentile","year":"2008","journal-title":"Clin Drug Invest"},{"key":"R17-7-20210206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.08r04468","article-title":"SSRI-exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine","volume":"70","author":"Gentile","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R18-7-20210206","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R19-7-20210206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Def Res Part B"},{"key":"R20-7-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","article-title":"Antidepressants in amniotic fluid: another route of fetal exposure","volume":"163","author":"Loughhead","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R24-7-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00148581-200709020-00003","article-title":"SRI-induced perinatal complications","volume":"9","author":"Gentile","year":"2007","journal-title":"Paediatr Drugs"},{"key":"R26-7-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"New Engl J Med"},{"key":"R27-7-20210206","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"K\u00e4ll\u00e9n","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R28-7-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and the risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R29-7-20210206","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"key":"R30-7-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1092852900027449","article-title":"On categorizing gestational, birth, and neonatal complications following late in utero exposure to antidepressants. The Prenatal Antidepressant Exposure Syndrome","volume":"15","author":"Gentile","year":"2010","journal-title":"CNS Spectr"},{"key":"R31-7-20210206","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpediatrics.2009.164","article-title":"Selective reuptake inhibitor exposure in utero and pregnancy outcome","volume":"163","author":"Lund","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R32-7-20210206","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery outcome in relation to maternal use of some recently introduced antidepressants","volume":"27","author":"Lennest\u00e5l","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R33-7-20210206","first-page":"95","article-title":"Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review","volume":"45","author":"Yacoby","year":"2008","journal-title":"Isr J Psy Relat Sci"},{"key":"R34-7-20210206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00048670903487217","article-title":"Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care","volume":"44","author":"Galbally","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"R35-7-20210206","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy","volume":"162","author":"Newport","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R36-7-20210206","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-5618.2006.00295.x","article-title":"Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers","volume":"8","author":"Gentile","year":"2006","journal-title":"Bipol Disord"},{"key":"R37-7-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12325-009-0011-z","article-title":"Teratogenesis associated with antibipolar agents","volume":"26","author":"Nguyen","year":"2009","journal-title":"Adv Ther"},{"key":"R38-7-20210206","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2009.11.008","article-title":"Liverpool and Manchester Neurodevelopment Group. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study","volume":"19","author":"Mawer","year":"2010","journal-title":"Seizure"},{"key":"R39-7-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"key":"R40-7-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1528-1167.2009.02336.x","article-title":"The teratogenic risk of antiepileptic drug polytherapy","volume":"51","author":"Vajda","year":"2010","journal-title":"Epilepsia"},{"key":"R41-7-20210206","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ncl.2009.06.006","article-title":"Teratogenic effects of antiepileptic medications","volume":"27","author":"Tomson","year":"2009","journal-title":"Neurol Clin"},{"key":"R42-7-20210206","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"key":"R43-7-20210206","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.wnl.0000316194.98475.d8","article-title":"EUROCAT Antiepileptic Drug Working Group. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?","volume":"71","author":"Dolk","year":"2008","journal-title":"Neurology"},{"key":"R44-7-20210206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/WCO.0b013e32832923d7","article-title":"Managing antiepileptic drugs during pregnancy and lactation","volume":"22","author":"Sabers","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"R45-7-20210206","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy","volume":"50","author":"Veiby","year":"2009","journal-title":"Epilepsia"},{"key":"R46-7-20210206","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R47-7-20210206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R48-7-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","article-title":"Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes","volume":"30","author":"Coppola","year":"2007","journal-title":"Drug Saf"},{"key":"R49-7-20210206","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotics during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R50-7-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JCP.0b013e3181db8734","article-title":"Birth weight and use of olanzapine during pregnancy: a prospective comparative study","volume":"30","author":"Babu","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R51-7-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr Res"},{"key":"R52-7-20210206","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1089\/jwh.2009.1431","article-title":"Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum","volume":"18","author":"Feizo","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"R53-7-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1701-2163(16)34432-2","article-title":"Obesity in pregnancy","volume":"32","author":"Davies","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"R54-7-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/cncr.20013","article-title":"Long-term risk of malignant neoplasm associated with gestational glucose intolerance","volume":"100","author":"Davson","year":"2004","journal-title":"Cancer"},{"key":"R55-7-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2982.2009.01409.x","article-title":"Constipation: a potential cause of pelvic floor damage?","volume":"22","author":"Amselem","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"R57-7-20210206","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":"Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R58-7-20210206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"A register study of impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"R60-7-20210206","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/WNF.0b013e318064579f","article-title":"A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder","volume":"30","author":"Dannon","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R61-7-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11319480-000000000-00000","article-title":"Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis","volume":"24","author":"Watanabe","year":"2010","journal-title":"CNS Drugs"},{"key":"R62-7-20210206","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/0269881109106953","article-title":"Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.","volume":"24","author":"Hewett","year":"2010","journal-title":"J Psychopharmacol"},{"key":"R63-7-20210206","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and the risk of attention-deficit\/hyperactivity disorder in the offspring.","volume":"31","author":"Figueroa","year":"2010","journal-title":"J Dev Behav Pediatr"},{"key":"R64-7-20210206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonization in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"R65-7-20210206","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive functions at 3 years after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"New Engl J Med"},{"key":"R66-7-20210206","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"R67-7-20210206","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/schbul\/sbn107","article-title":"Antipsychotic therapy during early and late pregnancy: a systematic review","volume":"36","author":"Gentile","year":"2010","journal-title":"Schizophrenia Bull"},{"key":"R68-7-20210206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1467-789X.2009.00589.x","article-title":"Contributing factors to weight gain during long-term treatment with second-generation antipsychotics: a systematic appraisal and clinical implications","volume":"10","author":"Gentile","year":"2009","journal-title":"Obesity Rev"},{"key":"R69-7-20210206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200629040-00002","article-title":"Long term atypical antipsychotics treatment and risk of weight gain: a literature analysis","volume":"29","author":"Gentile","year":"2006","journal-title":"Drug Saf"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/YCO.0b013e3283413451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:02Z","timestamp":1786041542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001504-201101000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0b013e3283413451","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}